Diabetes Clinical Trial
Official title:
The Diabetic Foot: Relevance of Vascular Progenitor Cells as a Prognostic Marker of Cardiovascular Mortality, Restenosis, and Atherosclerotic Disease Progression in Treated Limb.
Type of Study: Pilot Study monocenter Study Duration: 18 months Subject Participation
Duration: The patients are enrolled for the time of the blood withdrawl.
Follow up visit will be after 12 months from the enrollement.
Objectives:
The project will have two major objectives:
A)To validate the prognostic value of vascular progenitor cells, identified by flow
cytometric analysis of antigenic phenotype, in a cohort of 109 patients with type-2 diabetes
complicated by ischemic foot ulcers. Events are: cardiovascular mortality, major amputation,
post-angioplasty restenosis , and development of new atherosclerotic plaques in treated limb
B)To determine the mechanisms responsible for vascular progenitor cell dysfunction in the
perspective of new therapies for the cure of the diabetic foot.
This collaborative project aims to produce significant outputs for the identification of
patients requiring intensification of therapy. Furthermore, the project will fill the gap in
current knowledge on the post-genomic alterations that render diabetic vascular progenitor
cells dysfunctional. In perspective, this might help us to design new therapies for the cure
of the diabetic foot, including but not limited to stem cell therapy.
Primary Objectives:
To validate the prognostic value of vascular progenitor cells, identified by flow cytometric
analysis of antigenic phenotype, in a cohort of 109 patients with type-2 diabetes
complicated by ischemic foot ulcers.
Events are:
Cardiovascular mortality Major amputation Post-angioplasty restenosis Development of new
atherosclerotic plaques in treated limb (follow up: 12 months).
Secondary Objectives:
To determine the mechanisms responsible for vascular progenitor cell dysfunction in the
perspective of new therapies for the cure of the diabetic foot.
All the Units will contribute to the primary objective (to validate the prognostic value of
vascular progenitor cells, identified by flow cytometric analysis of antigenic phenotype, in
a cohort of 100 patients with type-2 diabetes complicated by ischemic foot ulcers).
Furthermore, each Unit will focus on specific mechanistic targets, according to pilot data
collected in previous and ongoing projects.
Dr Faglia, Head of the Diabetology Unit, Diabetic Foot Centre (IRCCS Multimedica-MM), will
conduct the selection and enrollement of the patients, and collect all the clinical data for
the study at the 12 month follow up visit.
The Unit leaded by Prof. Madeddu (IRCCS Multimedica), will perform the antigenic
characterization of the vascular progenitor cells by flow cytometry, and conduct the
migration assays.
The Unit leaded by Prof. Madeddu (IRCCS Multimedica)and the Unit leaded by Dr. Gaetano and
Martelli (IDI, Rome) will be engaged with determining whether vascular progenitor cells
dysfunction is mediated by specific epigenetic modifications. Epigenetics refers to the
covalent modifications found in chromatin, on both the DNA and the accompanying histone
proteins.
The Unit of Dr. Germani (IDI, Rome) will be focused on identification of growth factors,
chemokines and cytokines in the serum of diabetic patients that could be involved in the
deregulation of progenitor functions.
Since normal criteria are not already available, to conduct the analyses performed by the UO
IDI, we need to enrol a group of 30 not-diabetic subjects age- and sex-matched to identify
key changes to analyze in the entire group of patients.
Thirty patients coming to MM, UO Vascular Surgery, Dr Losa, for varicose vein treatment or
carotid stenosis will be enrolled and subjected to blood withdrawal as described for the
diabetic patients group.
Subject Inclusion Criteria:
Adult diabetic patients type 1 or 2, both men and women, with chronic critical ischemia as
defined by TASC 2007 criteria (pain at rest, and/or ulcer or gangrene due to artheropaty:
transcutaneous oximetry < 30 mmHg or pressure on the ankle < 70 mmHg).
Subject Exclusion Criteria:
- Cancer with adverse prognosis in months, or chemotherapic treatment
- Ongoing or planned pregnancy
- Lack of consent to participate to the study
Patients enrolment
At this time all patients will undergo all the following exams:
- General comprehensive visit (including: Chest RX, Rest ECG, and glycaemia plus
glycosilated haemoglobin measurement)
- Ankle arterial pressure (Doppler cw measurement)
- Angiographyc study and angioplasty,if feasible, in the same time
IMPORTANT NOTE: At the enrolment visit and at follow up visit after 12 months will be
performed:
- Ecodoppler
- Transcutaneous oximetry
- Completion of antigenic profiling
- Assessment of migratory capacity
- Characterization of major epigenetic signatures
- Paracrine profiling
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05594446 -
Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
|
||
Completed |
NCT03975309 -
DHS MIND Metabolomics
|
||
Completed |
NCT01855399 -
Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes
|
N/A | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
Recruiting |
NCT05007990 -
Caregiving Networks Across Disease Context and the Life Course
|
||
Active, not recruiting |
NCT04420936 -
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program
|
N/A | |
Recruiting |
NCT03549559 -
Imaging Histone Deacetylase in the Heart
|
N/A | |
Completed |
NCT04903496 -
Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
|
||
Completed |
NCT01437592 -
Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT03390179 -
Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Recruiting |
NCT05294822 -
Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes
|
N/A | |
Completed |
NCT04427982 -
Dance and Diabetes/Prediabetes Self-Management
|
N/A | |
Completed |
NCT02356848 -
STEP UP to Avert Amputation in Diabetes
|
N/A | |
Completed |
NCT03292185 -
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
|
Phase 1 | |
Active, not recruiting |
NCT05477368 -
Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes
|
N/A | |
Completed |
NCT04496401 -
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
|
Phase 4 |